Literature DB >> 9343225

Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus.

J E Fischer1, J E Johnson, R K Kuli-Zade, T R Johnson, S Aung, R A Parker, B S Graham.   

Abstract

Although interleukin-4 (IL-4) expression has been implicated in vaccine-enhanced respiratory syncytial virus (RSV) disease, its role in mediating the immune response to primary RSV infection remains unclear. To assess the effect of IL-4 production on typical RSV infection, transgenic mice which either overexpress or fail to express IL-4 were challenged intranasally with RSV and their responses were compared to those of the parent strains. IL-4-deficient mice eliminated virus from the lung as quickly as did C57BL/6 controls. In contrast, mice which constitutively overexpress IL-4 showed delayed virus clearance compared with mice of the FVB/N control strain, although peak viral titers did not differ. IL-4 overexpression increased the magnitude of the subsequent antibody response. Lung lymphocytes harvested from IL-4-overexpressing mice post-RSV challenge showed diminished RSV-specific cytolytic activity compared with controls. Both IL-4-deficient and IL-4-overexpressing strains resisted rechallenge. These data imply that constitutive IL-4 expression delays or suppresses the development of a virus-specific cytotoxic lymphocyte population important in clearing primary RSV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9343225      PMCID: PMC192331     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals.

Authors:  M Clerici; F T Hakim; D J Venzon; S Blatt; C W Hendrix; T A Wynn; G M Shearer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

2.  Interleukin-4 causes delayed virus clearance in influenza virus-infected mice.

Authors:  T M Moran; H Isobe; A Fernandez-Sesma; J L Schulman
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

3.  Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus.

Authors:  Y W Tang; B S Graham
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

4.  Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.

Authors:  B S Graham; T H Davis; Y W Tang; W C Gruber
Journal:  Pediatr Res       Date:  1993-08       Impact factor: 3.756

5.  Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.

Authors:  B S Graham; G S Henderson; Y W Tang; X Lu; K M Neuzil; D G Colley
Journal:  J Immunol       Date:  1993-08-15       Impact factor: 5.422

6.  Disruption of the murine IL-4 gene blocks Th2 cytokine responses.

Authors:  M Kopf; G Le Gros; M Bachmann; M C Lamers; H Bluethmann; G Köhler
Journal:  Nature       Date:  1993-03-18       Impact factor: 49.962

7.  The relationship of RSV-specific immunoglobulin E antibody responses in infancy, recurrent wheezing, and pulmonary function at age 7-8 years.

Authors:  R C Welliver; L Duffy
Journal:  Pediatr Pulmonol       Date:  1993-01

Review 8.  Lymphokine production by human T cells in disease states.

Authors:  S Romagnani
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

9.  T cell genetic background determines default T helper phenotype development in vitro.

Authors:  C S Hsieh; S E Macatonia; A O'Garra; K M Murphy
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

10.  Distinct types of lung disease caused by functional subsets of antiviral T cells.

Authors:  W H Alwan; W J Kozlowska; P J Openshaw
Journal:  J Exp Med       Date:  1994-01-01       Impact factor: 14.307

View more
  47 in total

1.  Creation of killer poxvirus could have been predicted.

Authors:  A Müllbacher; M Lobigs
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

2.  A defective type 1 response to rhinovirus in atopic asthma.

Authors:  N G Papadopoulos; L A Stanciu; A Papi; S T Holgate; S L Johnston
Journal:  Thorax       Date:  2002-04       Impact factor: 9.139

3.  Central role of dendritic cells in shaping the adaptive immune response during respiratory syncytial virus infection.

Authors:  Daniel S McDermott; Kayla A Weiss; Cory J Knudson; Steven M Varga
Journal:  Future Virol       Date:  2011-08       Impact factor: 1.831

4.  Effects of allergic airway disease on mouse adenovirus type 1 respiratory infection.

Authors:  Victoria E Anderson; Yn Nguyen; Jason B Weinberg
Journal:  Virology       Date:  2009-06-28       Impact factor: 3.616

5.  Establishment of NF-κB sensing and interleukin-4 secreting mesenchymal stromal cells as an "on-demand" drug delivery system to modulate inflammation.

Authors:  Tzuhua Lin; Jukka Pajarinen; Akira Nabeshima; Laura Lu; Karthik Nathan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2017-07-21       Impact factor: 5.414

6.  Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.

Authors:  R J Jackson; A J Ramsay; C D Christensen; S Beaton; D F Hall; I A Ramshaw
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

Review 7.  Animal pneumoviruses: molecular genetics and pathogenesis.

Authors:  Andrew J Easton; Joseph B Domachowske; Helene F Rosenberg
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

8.  Disruption of the airway epithelial barrier in a murine model of respiratory syncytial virus infection.

Authors:  Carrie C Smallcombe; Debra T Linfield; Terri J Harford; Vladimir Bokun; Andrei I Ivanov; Giovanni Piedimonte; Fariba Rezaee
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-11-29       Impact factor: 5.464

9.  Transplanted interleukin-4--secreting mesenchymal stromal cells show extended survival and increased bone mineral density in the murine femur.

Authors:  Tzuhua Lin; Jukka Pajarinen; Yusuke Kohno; Masahiro Maruyama; Monica Romero-Lopez; Jhih-Fong Huang; Karthik Nathan; Tahsin N Khan; Zhenyu Yao; Stuart B Goodman
Journal:  Cytotherapy       Date:  2018-08-02       Impact factor: 5.414

10.  Second-generation HIF-activated oncolytic adenoviruses with improved replication, oncolytic, and antitumor efficacy.

Authors:  T Cherry; S L Longo; Z Tovar-Spinoza; D E Post
Journal:  Gene Ther       Date:  2010-07-22       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.